ATE279919T1 - Agmatin für die behandlung neuropathischer schmerzen - Google Patents

Agmatin für die behandlung neuropathischer schmerzen

Info

Publication number
ATE279919T1
ATE279919T1 AT98942082T AT98942082T ATE279919T1 AT E279919 T1 ATE279919 T1 AT E279919T1 AT 98942082 T AT98942082 T AT 98942082T AT 98942082 T AT98942082 T AT 98942082T AT E279919 T1 ATE279919 T1 AT E279919T1
Authority
AT
Austria
Prior art keywords
agmatine
treatment
neuropathic pain
administering
composition
Prior art date
Application number
AT98942082T
Other languages
English (en)
Inventor
Carolyn Ann Fairbanks
George L Wilcox
Kristin Schreiber
Tinna Marie Laughlin
Original Assignee
Carolyn Ann Fairbanks
George L Wilcox
Kristin Schreiber
Tinna Marie Laughlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carolyn Ann Fairbanks, George L Wilcox, Kristin Schreiber, Tinna Marie Laughlin filed Critical Carolyn Ann Fairbanks
Application granted granted Critical
Publication of ATE279919T1 publication Critical patent/ATE279919T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT98942082T 1997-08-15 1998-08-17 Agmatin für die behandlung neuropathischer schmerzen ATE279919T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5584797P 1997-08-15 1997-08-15
PCT/US1998/017033 WO1999008669A1 (en) 1997-08-15 1998-08-17 Agmatine as a treatment for neuropathic pain

Publications (1)

Publication Number Publication Date
ATE279919T1 true ATE279919T1 (de) 2004-11-15

Family

ID=22000542

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98942082T ATE279919T1 (de) 1997-08-15 1998-08-17 Agmatin für die behandlung neuropathischer schmerzen

Country Status (6)

Country Link
US (1) US6150419A (de)
EP (1) EP1014959B1 (de)
AT (1) ATE279919T1 (de)
AU (1) AU9021298A (de)
DE (1) DE69827149T2 (de)
WO (1) WO1999008669A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
EA006598B1 (ru) * 1999-08-20 2006-02-24 Орто-Макнейл Фармасьютикал, Инк. Композиция, содержащая трамадол и противосудорожное лекарственное средство
WO2001095897A1 (en) * 2000-06-15 2001-12-20 University Of Kentucky Research Foundation Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders
EP1395289B1 (de) * 2001-06-07 2010-12-15 Christine Dr. Sang Behandlung von neuropathischen schmerzen mittels eines n-methyl-d-aspartate (nmda)-rezeptor-antagonists
AR049646A1 (es) * 2004-06-16 2006-08-23 Janssen Pharmaceutica Nv Derivados de sulfamato y sulfamida utiles para el tratamiento de la epilepsia y trastornos relacionados
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MY142329A (en) * 2004-08-24 2010-11-15 Janssen Pharmaceutica Nv Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents.
US20060199237A1 (en) * 2005-03-02 2006-09-07 Smith Daniel J Clinical assay for monitoring of agmatine
KR20080012360A (ko) * 2005-05-20 2008-02-11 얀센 파마슈티카 엔.브이. 설파미드 유도체의 제조 방법
US8691867B2 (en) * 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8716231B2 (en) * 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8937096B2 (en) * 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US20070155823A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
US8497298B2 (en) * 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US20070155827A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
US8492431B2 (en) * 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US20070191449A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression
US20070191474A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
US20070191452A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of pain
US20070191461A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine
EA200870556A1 (ru) * 2006-05-19 2009-06-30 Янссен Фармацевтика Н.В. Комбинированная терапия в лечении эпилепсии и родственных расстройств
KR100854207B1 (ko) 2007-04-04 2008-08-26 성공제 아그마틴의 망막 신경절 세포 보호 용도
US20090247617A1 (en) * 2008-03-26 2009-10-01 Abdel-Magid Ahmed F Process for the preparation of benzo-fused heteroaryl sulfamates
US20090247616A1 (en) * 2008-03-26 2009-10-01 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
BRPI0915890A2 (pt) 2008-06-23 2015-11-03 Janssen Pharmaceutica Nv forma cristalina de (2s)-(-)-n-(6-cloro-2,3-di-hidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida
US8815939B2 (en) * 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
WO2010030470A1 (en) * 2008-09-11 2010-03-18 Gilad Gad M Agmatine containing dietary supplements, nutraceuticals, and foods
US8916612B2 (en) * 2008-09-11 2014-12-23 Gad Gilad Agmatine containing dietary supplements, nutraceuticals, and foods
FR2985427B1 (fr) 2012-01-10 2016-07-15 Nutrialys Medical Nutrition Sa Compositions contenant de l'agmatine et leurs utilisations dans la preparation de medicaments ou de substances nutraceutiques
US12098118B2 (en) * 2018-11-07 2024-09-24 Regents Of The University Of Minnesota Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction
WO2020132195A1 (en) * 2018-12-21 2020-06-25 Strontium Neurogenics Inc. Strontium based compositions and formulations for pain, pruritus, and inflammation
US12036193B2 (en) 2019-09-15 2024-07-16 Celagenex Research (India) Pvt. Ltd. Synergistic bioactive compositions for treating neurological disorders
US11622949B1 (en) 2022-08-04 2023-04-11 Gad M. Gilad Agmatine compositions for treatment of osteoarthritis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507321A (en) * 1982-02-17 1985-03-26 The Research Foundation Of State University Of New York Epithelial cell growth regulating composition containing polyamines and a method of using same
AT393079B (de) * 1989-03-06 1991-08-12 Lubec Gert Pharmazeutische verwendung von agmatin
SE468881B (sv) * 1991-01-09 1993-04-05 Kabi Pharmacia Ab Anvaendning av vissa foereningar foer framstaellning av laekemedel foer behandling av endotoxininducerade effekter samt saett att avlaegsna endotoxiner ur diverse loesningar
WO1993013128A1 (en) * 1991-12-30 1993-07-08 Neurex Corporation Methods of producing analgesia and enhancing opiate analgesia
US5352683A (en) * 1993-03-05 1994-10-04 Virginia Commonwealth University Medical College Of Virginia Method for the treatment of chronic pain
US5534495A (en) * 1993-05-25 1996-07-09 Advanced Peptides And Biotechnology Sciences Treatment of non-HIV neuropathic pain syndromes
US5849737A (en) * 1995-04-14 1998-12-15 The Regents Of The University Of California Compositions and methods for treating pain
US5677349A (en) * 1995-04-27 1997-10-14 Gilad; Gad M. Agmatine for the treatment of neurotrauma and neurodegenerative diseases
US5574059A (en) * 1995-10-27 1996-11-12 Cornell Research Foundation, Inc. Treating disorders mediated by vascular smooth muscle cell proliferation

Also Published As

Publication number Publication date
AU9021298A (en) 1999-03-08
EP1014959A1 (de) 2000-07-05
DE69827149T2 (de) 2006-03-09
US6150419A (en) 2000-11-21
EP1014959B1 (de) 2004-10-20
WO1999008669A1 (en) 1999-02-25
DE69827149D1 (de) 2004-11-25
EP1014959A4 (de) 2001-05-09

Similar Documents

Publication Publication Date Title
DE69827149D1 (de) Agmatin für die behandlung neuropathischer schmerzen
EP0792137A4 (de) Pilzhemmende behandlung für die nägel
ATE234090T1 (de) Kombination von duloxetin mit nichtsteroid- entzündungshemmern für die behandlung von schmerz
DE69927823T2 (de) Hydrogel für die therapeutische behandlung von aneurysmas
TR199902802T2 (xx) Kardiyovask�ler hastal�klar ve enflamatuar hastal�klar�n tedavisi i�in probukol monoesterleri.
BG101966A (en) Application of 1l-agonist for the treatment of lack of urine retention
DE69412807D1 (de) Einrichtung zur abgabe von elektrischen impulsen für die behandlung biologischer gewebe
IL138402A0 (en) Heterocyclically substituted amides used as calpain inhibitors
DE69518037D1 (de) Klebstoffmischung für die Zahnbehandlung
EP0813544A4 (de)
DE3480764D1 (de) Behandlung von anfaellen und hierfuer nuetzliche pharmazeutische zusammensetzungen.
ATE305517T1 (de) Neurotrypsin
ATE28188T1 (de) Antikonvulsive mittel.
IL139144A0 (en) Mycobacterial inhibitors
ATE274905T1 (de) 4,5-dihydroxy-2-cyclopentene-1-on für die behandlung von rheumatismus, entzündungen und autoimmunerkrankungen
PL318292A1 (en) Application of selegyline in treating epileptic seizures
ATE253556T1 (de) Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
IL139303A0 (en) Treatment of arthritis and other similar conditions
ATE270113T1 (de) Zusammenstellungen zur verbesserten wundheilung
ATE306269T1 (de) Behandlung der exzessiven aggressivität mit olanzapine
EP1011672A4 (de) Verbindungen mit analgetischem effekt und zusammenstellungen die diese enthalten
MD775F1 (en) The 2-hydroxynaphthyl-1-methinehydrazone of 5-nitro- 2-furaldehyde synthesis method
MX9801683A (es) Composiciones y metodos para controlar hongos perjudiciales.
UA43389C2 (uk) Спосіб зниження рівнів кальцію у сироватці

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1014959

Country of ref document: EP

REN Ceased due to non-payment of the annual fee